iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study
ClinicalTrials.gov NCT04624698
Research payments
$1,323,704
Through program year 2021, $1,323,704 in research payments was reported against iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study, across 198 payments, paid by Glaukos Corporation.
- Paid by
- Glaukos Corporation
- ClinicalTrials.gov
- NCT04624698
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $1,288,143 | 179 |
| 2020 | Research | $35,561 | 19 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gang Hu Hurst, TX Named on 15 payments
- Damien Goldberg Torrance, CA Named on 15 payments
- John Berdahl Sioux Falls, SD Named on 15 payments
- David Slade St George, UT Named on 15 payments
- Russell Swan Sioux Falls, SD Named on 14 payments
- Joseph Kavanagh San Antonio, TX Named on 14 payments
- Steven Sarkisian Oklahoma City, OK Named on 13 payments
- Benjamin Heller Phoenix, AZ Named on 13 payments
- Davinder Grover Dallas, TX Named on 12 payments
- Michael Greenwood Sioux Falls, SD Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.